Protein name:
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha;PI3K-alpha;PI3Kalpha;PtdIns-3-kinase subunit alpha) ;
Alternative:
Phosphoinositide-3-kinase catalytic alpha polypeptide ;Phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha (PtdIns-3-kinase subunit p110-alpha;p110alpha) ;2.7.11.1;Serine/threonine protein kinase PIK3CA ) ;
Organism:
Human (Homo sapiens).
General Annotation
Sub Unit:
Heterodimer of a catalytic subunit PIK3CA and a p85 regulatory subunit (PIK3R1, PIK3R2 or PIK3R3). Interacts with IRS1 in nuclear extracts. Interacts with RUFY3 (By similarity). Interacts with RASD2 (By similarity). Interacts with APPL1. Interacts with HRAS1 and KRAS (By similarity). Interaction with HRAS1/KRAS is required for PI3K pathway signaling and cell proliferation stimulated by EGF and FGF2.
Function:
Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns (Phosphatidylinositol), PtdIns4P (Phosphatidylinositol 4-phosphate) and PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol-3,4,5-triphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation in breast cancer cells through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. Has also serine-protein kinase activity: phosphorylates PIK3R1 (p85alpha regulatory subunit), EIF4EBP1 and HRAS.
Subcellular Location:
N/A
Protein Attributes:
50:
MPPRPSSGEL | WGIHLMPPRI | LVECLLPNGM | IVTLECLREA | TLITIKHELF |
100:
KEARKYPLHQ | LLQDESSYIF | VSVTQEAERE | EFFDETRRLC | DLRLFQPFLK |
150:
VIEPVGNREE | KILNREIGFA | IGMPVCEFDM | VKDPEVQDFR | RNILNVCKEA |
200:
VDLRDLNSPH | SRAMYVYPPN | VESSPELPKH | IYNKLDKGQI | IVVIWVIVSP |
250:
NNDKQKYTLK | INHDCVPEQV | IAEAIRKKTR | SMLLSSEQLK | LCVLEYQGKY |
300:
ILKVCGCDEY | FLEKYPLSQY | KYIRSCIMLG | RMPNLMLMAK | ESLYSQLPMD |
350:
CFTMPSYSRR | ISTATPYMNG | ETSTKSLWVI | NSALRIKILC | ATYVNVNIRD |
400:
IDKIYVRTGI | YHGGEPLCDN | VNTQRVPCSN | PRWNEWLNYD | IYIPDLPRAA |
450:
RLCLSICSVK | GRKGAKEEHC | PLAWGNINLF | DYTDTLVSGK | MALNLWPVPH |
500:
GLEDLLNPIG | VTGSNPNKET | PCLELEFDWF | SSVVKFPDMS | VIEEHANWSV |
550:
SREAGFSYSH | AGLSNRLARD | NELRENDKEQ | LKAISTRDPL | SEITEQEKDF |
600:
LWSHRHYCVT | IPEILPKLLL | SVKWNSRDEV | AQMYCLVKDW | PPIKPEQAME |
650:
LLDCNYPDPM | VRGFAVRCLE | KYLTDDKLSQ | YLIQLVQVLK | YEQYLDNLLV |
700:
RFLLKKALTN | QRIGHFFFWH | LKSEMHNKTV | SQRFGLLLES | YCRACGMYLK |
750:
HLNRQVEAME | KLINLTDILK | QEKKDETQKV | QMKFLVEQMR | RPDFMDALQG |
800:
FLSPLNPAHQ | LGNLRLEECR | IMSSAKRPLW | LNWENPDIMS | ELLFQNNEII |
850:
FKNGDDLRQD | MLTLQIIRIM | ENIWQNQGLD | LRMLPYGCLS | IGDCVGLIEV |
900:
VRNSHTIMQI | QCKGGLKGAL | QFNSHTLHQW | LKDKNKGEIY | DAAIDLFTRS |
950:
CAGYCVATFI | LGIGDRHNSN | IMVKDDGQLF | HIDFGHFLDH | KKKKFGYKRE |
1000:
RVPFVLTQDF | LIVISKGAQE | CTKTREFERF | QEMCYKAYLA | IRQHANLFIN |
1050:
LFSMMLGSGM | PELQSFDDIA | YIRKTLALDK | TEQEALEYFM | KQMNDAHHGG |
1068:
WTTKMDWIFH | TIKQHALN
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Bovine
Human
Mouse
ELISA Kit for Human PI3-kinase subunit alpha
ELISA Kit for Human PI3-kinase subunit alpha
ELISA Kit for Human PI3-kinase subunit alpha
CLIA Kit for Human PI3-kinase subunit alpha
CLIA Kit for Human PI3-kinase subunit alpha
CLIA Kit for Human PI3-kinase subunit alpha
Polyclonal Antibody for Human PI3-kinase subunit alpha
Polyclonal Antibody for Human PI3-kinase subunit alpha
Polyclonal Antibody for Human PI3-kinase subunit alpha
Monoclonal Antibody for Human PI3-kinase subunit alpha
Monoclonal Antibody for Human PI3-kinase subunit alpha
Monoclonal Antibody for Human PI3-kinase subunit alpha
Protein for Human PI3-kinase subunit alpha
Protein for Human PI3-kinase subunit alpha
Protein for Human PI3-kinase subunit alpha
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
References
1.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA];VARIANTS VAL-43 AND ARG-332
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA]
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
tissue :
Lung .
4.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INTERACTION WITH APPL1
5.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : FUNCTION IN INVADOPODIA FORMATION;CHARACTERIZATION OF VARIANTS LYS-545 AND ARG-1047
6.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : REVIEW ON CANCER
7.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : REVIEW ON FUNCTION;REVIEW ON CANCER
8.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : REVIEW ON FUNCTION
9.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (3 ANGSTROMS) IN A COMPLEX WITH PIK3R1;DOMAINS
10.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : STRUCTURE BY NMR OF 331-481
11.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF MUTANT HIS-1047 IN COMPLEX WITH WORTMANNIN AND PIK3R1;INTERACTION WITH PIK3R1;CHARACTERIZATION OF VARIANT ARG-1047;DOMAINS
12.
"Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas."
Broderick D.K.
,
Di C.
,
Parrett T.J.
,
Samuels Y.R.
,
Cummins J.M.
,
McLendon R.E.
,
Fults D.W.
,
Velculescu V.E.
,
Bigner D.D.
,
Yan H.
Cancer Res.64:5048-5050(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER LYS-542; LYS-545; PRO-546; ASN-1021; ARG-1047; LEU-1047 AND TYR-1065
13.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER GLY-545; LYS-545; LYS-546; GLU-546; ARG-1047 AND LEU-1047
14.
"High frequency of mutations of the PIK3CA gene in human cancers."
Samuels Y.
,
Wang Z.
,
Bardelli A.
,
Silliman N.
,
Ptak J.
,
Szabo S.
,
Yan H.
,
Gazdar A.
,
Powell S.M.
,
Riggins G.J.
,
Willson J.K.V.
,
Markowitz S.
,
Kinzler K.W.
,
Vogelstein B.
,
Velculescu V.E.
Science304:554-554(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT CANCER ARG-1047
15.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER GLN-88; LYS-542; ALA-545 AND ASN-1025
16.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER LYS-542; LYS-545 AND ARG-1047
17.
"Functional analysis of PIK3CA gene mutations in human colorectal cancer."
Ikenoue T.
,
Kanai F.
,
Hikiba Y.
,
Obata T.
,
Tanaka Y.
,
Imamura J.
,
Ohta M.
,
Jazag A.
,
Guleng B.
,
Tateishi K.
,
Asaoka Y.
,
Matsumura M.
,
Kawabe T.
,
Omata M.
Cancer Res.65:4562-4567(2005)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : CHARACTERIZATION OF VARIANTS CRC HIS-38; VAL-106; ARG-420; GLN-453; LYS-542; LYS-545; ILE-1043 AND ARG-1047
18.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER GLN-542; LYS-542; GLY-545; LYS-545; ARG-1007; HIS-1021; CYS-1021; VAL-1035; ILE-1043; TYR-1047; ARG-1047; ASP-1050; LYS-1052 AND LEU-1065
19.
"The prevalence of PIK3CA mutations in gastric and colon cancer."
Velho S.
,
Oliveira C.
,
Ferreira A.
,
Ferreira A.C.
,
Suriano G.
,
Schwartz S. Jr.
,
Duval A.
,
Carneiro F.
,
Machado J.C.
,
Hamelin R.
,
Seruca R.
Eur. J. Cancer41:1649-1654(2005)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER LYS-542; GLY-545; LYS-545; GLN-1023; ARG-1047 AND LEU-1047
20.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER LYS-545 AND ARG-1047
21.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT HCC ALA-545
22.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CANCER CYS-343; LYS-542; LYS-545 AND ARG-1047;VARIANT MET-391
23.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANT CANCER ARG-1047
24.
"PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma."
Buttitta F.
,
Felicioni L.
,
Barassi F.
,
Martella C.
,
Paolizzi D.
,
Fresu G.
,
Salvatore S.
,
Cuccurullo F.
,
Mezzetti A.
,
Campani D.
,
Marchetti A.
J. Pathol.208:350-355(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS BC LYS-542; VAL-542; LYS-545; ARG-546; ARG-1047 AND LEU-1047
25.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : CHARACTERIZATION OF VARIANTS CANCER LYS-542; LYS-545 AND ARG-1047
26.
"Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern."
Hafner C.
,
Lopez-Knowles E.
,
Luis N.M.
,
Toll A.
,
Baselga E.
,
Fernandez-Casado A.
,
Hernandez S.
,
Ribe A.
,
Mentzel T.
,
Stoehr R.
,
Hofstaedter F.
,
Landthaler M.
,
Vogt T.
,
Pujol R.M.
,
Hartmann A.
,
Real F.X.
Proc. Natl. Acad. Sci. U.S.A.104:13450-13454(2007)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS KERSEB LYS-542; LYS-545; GLY-545 AND ARG-1047
27.
"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome."
Kurek K.C.
,
Luks V.L.
,
Ayturk U.M.
,
Alomari A.I.
,
Fishman S.J.
,
Spencer S.A.
,
Mulliken J.B.
,
Bowen M.E.
,
Yamamoto G.L.
,
Kozakewich H.P.
,
Warman M.L.
Am. J. Hum. Genet.90:1108-1115(2012)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CLOVE ARG-420; LYS-542 AND ARG-1047
28.
"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes."
Riviere J.B.
,
Mirzaa G.M.
,
O'Roak B.J.
,
Beddaoui M.
,
Alcantara D.
,
Conway R.L.
,
St-Onge J.
,
Schwartzentruber J.A.
,
Gripp K.W.
,
Nikkel S.M.
,
Worthylake T.
,
Sullivan C.T.
,
Ward T.R.
,
Butler H.E.
,
Kramer N.A.
,
Albrecht B.
,
Armour C.M.
,
Armstrong L.
,
Caluseriu O.
,
Cytrynbaum C.
,
Drolet B.A.
,
Innes A.M.
,
Lauzon J.L.
,
Lin A.E.
,
Mancini G.M.
,
Meschino W.S.
,
Reggin J.D.
,
Saggar A.K.
,
Lerman-Sagie T.
,
Uyanik G.
,
Weksberg R.
,
Zirn B.
,
Beaulieu C.L.
,
Majewski J.
,
Bulman D.E.
,
O'Driscoll M.
,
Shendure J.
,
Graham J.M. Jr.
,
Boycott K.M.
,
Dobyns W.B.
more...
Nat. Genet.44:934-940(2012)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS MCAP LYS-81; GLN-88; ARG-364; LYS-365; TYR-378; GLU-453 DEL; LYS-545; LYS-726; ARG-914; CYS-1021; ALA-1025; VAL-1035; ILE-1043; TYR-1047 AND SER-1049
29.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : VARIANTS CWS5 ASP-118; LYS-135; LYS-218; ILE-356; LYS-382 AND ALA-545